EMERYVILLE, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- Biossance™, the pioneer of sustainable solutions in beauty from Amyris, Inc. (Nasdaq:AMRS), announced today the Blacklist ─ 2,000+ common cosmetic ingredients it refuses to use due to safety and environmental concerns. The regulatory environment in the U.S. affords cosmetic brands the opportunity to use potentially harmful ingredients in cosmetic products. Biossance has created higher standards by adopting rigorous ingredient selection guidelines and omitting ingredients that are potentially harmful to you or the planet.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/b1c11e3f-aa69-4a1a-a3b5-7f3aafc8553b
Since its inception, the brand has delivered significant growth while doing the right thing for consumers. This has enabled consumers to select effective products while avoiding using petroleum-based or other ingredients that are potentially harmful to their skin and our planet.
No Compromise ─ Only the Good, None of the Bad
Beginning with a list of 1,300+ ingredients banned in Europe, Biossance’s Blacklist now totals over 2,000 restricted ingredients, including conflict minerals, parabens and oxybenzone (used in products such as sunscreen and linked to mass die-offs in coral). The result is high-performing products for the skin that are:
- Results driven
- Safe for you and the planet
- Formulated without synthetic fragrances, parabens, phthalates, or mineral oil
- Ideal for all skin types
- Dermatologist and ophthalmologist tested
“Currently, the U.S. has low standards for ingredients formulated into beauty products and we have the opportunity to set the bar higher and also to continue demonstrating that our brand can do well by doing good,” said Caroline Hadfield, Amyris's Senior Vice President, Personal Care. “We don’t accept the status quo. We are leading the charge in the movement towards clean beauty by setting our standards high and supporting efforts for change like the Personal Care Products Safety Act.”
Incredibly, 1938 was the last year the Food & Drug Administration (FDA) updated its regulations on cosmetics safety and the U.S. maintains a very limited list of banned ingredients. Currently, it is up to cosmetic companies to create their own standards beyond that list. In order to support modernizing standards for all, Biossance is a strong supporter of the new Personal Care Products Safety Act, which would require the FDA to assess five new ingredients for safety every year.
Biossance™ pioneered sustainable 100% plant-based squalane to replenish your skin and enhance your biological beauty. The squalane-based brand was created in response to the prevalent use of squalane derived from sharks as an emollient in cosmetic products, creating devastating environmental impact. We’ve designed our line of squalane-based products to empower and inform you, so you can trust that what you are putting on your skin is safe. We won’t compromise, so we hand-select the most effective ingredients and avoid those that are potentially harmful to you or the planet. The full Biossance skin care and beauty collection can be found at http://biossance.com.
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.
Amyris, the Amyris logo, Biossance, and No Compromise are trademarks or registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
Contacts: Elle Communications Megan Noller (424) 634-8370 firstname.lastname@example.org or Lily Taban (661) 607-9397 email@example.com Amyris, Inc. Peter DeNardo Director, Investor Relations and Corporate Communications (510) 740-7481 firstname.lastname@example.org email@example.com